AJP - Regu Fuel your research with LabChart
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Am J Physiol Regul Integr Comp Physiol 280: R183-R190, 2001;
0363-6119/01 $5.00
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (27)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lane, R. H.
Right arrow Articles by Devaskar, S. U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lane, R. H.
Right arrow Articles by Devaskar, S. U.
Vol. 280, Issue 1, R183-R190, January 2001

Uteroplacental insufficiency alters hepatic fatty acid-metabolizing enzymes in juvenile and adult rats

Robert H. Lane1, David E. Kelley2, Elisa M. Gruetzmacher2, and Sherin U. Devaskar1

1 Department of Pediatrics, University of California Los Angeles School of Medicine, Mattel Children's Hospital at UCLA, Los Angeles, California 90095; and 2 Departments of Internal Medicine and Pediatrics, University of Pittsburgh School of Medicine, Magee-Womens Research Institute, Pittsburgh, Pennsylvania 15213


    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Multiple adult morbidities are associated with intrauterine growth retardation (IUGR) including dyslipidemia. We hypothesized that uteroplacental insufficiency and subsequent IUGR in the rat would lead to altered hepatic fatty acid metabolism. To test this hypothesis, we quantified hepatic mRNA levels of acetyl-CoA carboxylase (ACC), carnitine palmitoyltransferase (CPTI), the beta -oxidation-trifunctional protein (HADH), fasting serum triglycerides, and hepatic malonyl-CoA levels at different ages in control and IUGR rats. Fetal gene expression of all three enzymes was decreased. Juvenile gene expression of CPTI and HADH continued to be decreased, whereas gene expression of ACC was increased. Serum triglycerides were unchanged. A sex-specific response was noted in the adult rats. In males, serum triglycerides, hepatic malonyl-CoA levels, and ACC mRNA levels were significantly increased, and CPTI and HADH mRNA levels were significantly decreased. In contrast, the female rats demonstrated no significant changes in these variables. These results suggest that uteroplacental insufficiency leads to altered hepatic fatty acid metabolism that may contribute to the adult dyslipidemia associated with low birth weight.

intrauterine growth retardation; syndrome X; dyslipidemia


    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

UTEROPLACENTAL INSUFFICIENCY causes intrauterine growth retardation (IUGR) and is causally related to the development of multiple adult morbidities including insulin resistance, hypertension, coronary heart disease, and dyslipdemia (3, 5). The pathogenesis of how the transient in utero event of uteroplacental insufficiency affects adult metabolism is unknown.

We have previously demonstrated that uteroplacental insufficiency in the rat alters hepatic mitochondrial gene expression and function (27, 42). The mitochondria play a central role in cellular fatty acid biochemistry, and the liver contributes to whole body lipid homeostasis by oxidizing fatty acids and synthesizing triglycerides (48). We therefore hypothesized that induction of growth retardation in the rat by uteroplacental insufficiency would cause altered gene expression and function of key mitochondrial enzymes involved in hepatic fatty acid metabolism.

To test our hypothesis, we performed bilateral uterine artery ligation on pregnant Sprague-Dawley rats to induce uteroplacental insufficiency and subsequent growth retardation. We then quantified mRNA levels of three key mitochondrial enzymes involved in hepatic fatty acid metabolism at days 0, 21, and 120 of life in sham-operated (Con) and IUGR rats. These enzymes were acetyl-CoA carboxylase (ACC), the liver isoform of carnitine palmitoyltransferase I (CPTI), and the alpha -subunit of the trifunctional protein of beta -oxidation (HADHA).

ACC is the rate-limiting step in hepatic fatty acid synthesis and converts acetyl-CoA to malonyl-CoA (52). Malonyl-CoA inhibits CPTI (34). CPTI is a part of the carnitine shuttle and is conventionally thought to reside on the inner side of the mitochondrial outer membrane, which allows interaction between the malonyl-CoA-binding site and the translocase (33). CPTI is considered to be a rate-limiting transporter in mitochondrial fatty acid beta -oxidation.

Trifunctional protein of beta -oxidation (HADH) is an inner mitochondrial membrane protein that contributes three of the four reactions necessary for mitochondrial long-chain fatty acid oxidation. HADH is a protein complex made up of alpha - and beta -subunits. The beta -subunit demonstrates 3-oxoacyl-CoA thiolase activity, and the alpha -subunit (HADHA) demonstrates enoyl-CoA hydratase and 3-hydroxyacyl-CoA dehydrogenase activity (20, 35, 61). 3-Hydroxyacyl-CoA dehydrogenase activity is the rate-limiting step of this complex.

To assess effects of altered expression of these genes, we quantified hepatic malonyl-CoA levels in IUGR and control adult animals. Malonyl-CoA, the major precursor for hepatic fatty acid synthesis, plays a crucial role in the control of mitochondrial fatty acid oxidation (37). Furthermore, we determined whether changes in gene expression were associated with global dyslipidemia by quantifying fasting serum triglycerides on days 21 and 120 of life.

We found that uteroplacental insufficiency resulted in long-term changes in gene expression of all three enzymes as well as decreased weight in the male IUGR rats. The fact that changes in gene expression secondary to in utero environmental perturbations occur long after the initial insult raises the possibility that our findings are secondary to epigenetic phenomena. Epigenetic changes in DNA are potentially inheritable, and both paternal and maternal birth weights in humans influence progeny size (18, 23, 24, 31, 36). Therefore, we additionally examined the influence of paternal versus maternal IUGR on the progeny weight.


    METHODS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Animals. All procedures were approved by the Institutional Animal Care and Use Committee of the Magee-Womens Research Institute (Pittsburgh, PA). Timed pregnant Sprague-Dawley rats (Taconic Farms, Germantown, NY) were housed in individual cages and were exposed to 12:12-h light-dark cycles. All animals were fed routine Purina rat chow ad libitum (St. Louis, MO). The animals were allowed at least 2 days of acclimatization before experimental handling.

The rat model of uteroplacental insufficiency and IUGR used in this study is bilateral uterine artery ligation of the pregnant rat 48 h before term delivery. Fetal and neonatal rats in this model are significantly lighter than controls that undergo identical anesthesia and sham surgery, and litter size does not differ between control and IUGR groups (25). Like the human, the IUGR rat fetus is characterized by hypoxia, acidosis, altered insulin-like growth factor (IGF) availability, hypoglycemia, and hypoinsulinemia, all of which normalize in the perinatal period (40, 41, 59). At day 21 of postnatal life, both male and female IUGR rats weighed significantly less than Con counterparts.

On day 19 of gestation (term is 21.5 days), the maternal rats were anesthetized with intraperitoneal xylazine (8 mg/kg) and ketamine (40 mg/kg), and both inferior uterine arteries were ligated (IUGR; n = 24 litters). Sham surgery was performed on control animals that underwent identical anesthetic and surgical procedures except for the uterine artery ligation (Con; n = 24 litters) (26). Rats recovered within a few hours and had ad libitum access to food and water.

Day 0 pups were delivered by cesarean section (n = 10 Con and IUGR, respectively). The remaining maternal rats were allowed to deliver spontaneously, and litters were randomly culled to six on day 3 of life (to control for the effects of litter size on growth). On day 21 of life, animals were separated from their dams for 4 h (to minimize individual hormonal variations associated with feeding) and sedated with isoflurane inhalation just before death (n = 8 Con and IUGR, respectively). On day 60 of life, animals were weighed. On day 120 of life, the remaining animals were fasted for 8 h and sedated with isoflurane just before death (n = 6 Con and IUGR, respectively). For both age groups, blood was drawn by cardiac puncture after sedation, and liver was immediately harvested and frozen.

Between days 45 and 75 of life, the following rat pairs were mated: Con male with Con female, Con male with IUGR female, IUGR male with Con female, and IUGR male with IUGR female (n = 3 for each pair). Rats used in these matings were randomly selected and not used for any further studies. Pups were allowed to deliver spontaneously and were weighed on day 7 of postnatal life.

RNA isolation. Total RNA was extracted from brain by the method of Chomczynksi and Sacchi (9) and quantified in triplicate using ultraviolet absorbance at 260 nm. Gel electrophoresis confirmed the integrity of the samples. Bovine retinal RNA was prepared in a similar manner.

RT-PCR. A previously described and well-established method of semiquantitative RT-PCR was used for two reasons (28). First, RT-PCR requires relatively small amounts of tissues, which allowed quantification of multiple transcripts in fetal liver. Second, gene expression of all three enzymes correlate with enzyme activity (15, 44-46). cDNA was synthesized using random hexamers and Superscript II RT (Life Technologies, Gaithersburg, MD).

Amplification primers for ACC (30), CPTI (liver isoform) (13), and HAHDA (21) are listed in Table 1. For comparative purposes, RT-PCR was performed using primers for mitochondrial malate dehydrogenase (MMD) and isocitrate dehydrogenase (ICD), two Krebs cycle dehydrogenases not directly involved in fatty acid oxidation (Fig. 1) (17, 38). To determine reaction conditions when both amplicons were simultaneously produced exponentially, we reverse transcribed and amplified serial dilutions of rat RNA with standard amounts of retinal RNA under different conditions and cycle numbers. Once optimal conditions were predetermined, we ran a single-standard serial dilution with each quantification to regularly verify parallel production of both rat and bovine PCR-amplified products. Reactions were replicated three times once optimal PCR conditions were established, and the primer concentrations were identical across all ages and between study groups for each rat DNA target, respectively. The relative abundance of ACC, CPTI, and HADHA was quantified relative to that of a control rhodopsin band from the same reaction, which was assigned an arbitrary level of unity. To determine the specificity of the primers, the amplified products were sequenced, and absolute identification was made.

                              
View this table:
[in this window]
[in a new window]
  		Table 1.   Sequences of PCR primers



View larger version (28K):
[in this window]
[in a new window]
  		Fig. 1.   Cartoon of mitochondria and enzymes significant in this study. In bold print are the enzymes whose mRNA was measured in day 21 and day 120 sham-operated control or intrauterine growth-restricted (IUGR) liver. Acetyl-CoA carboxylase (ACC) is a rate-limiting enzyme in hepatic fatty acid synthesis. ACC synthesizes malonyl-CoA, which inhibits carnitine palmitoyltansferase I (CPTI). CPTI and the trifunctional protein of beta -oxidation (HADH) are enzymes that play significant roles in determining the rate of mitochondrial beta -oxidation.

Hepatic malonyl-CoA Levels. Malonyl-CoA was extracted from day 120 liver according to the method of Takeyama et al. (57). A reverse-phase high-performance liquid chromatography gradient procedure using a C18, 4-µm, 60A column with a C18 Nova-Pak guard column (Waters Nova-Pak, Water, Milford, MA) maintained at a 30°C temperature and the procedures of King and Reiss (22) were used for detection of malonyl-CoA. Concentrations of malonyl-CoA in the liver were calculated by comparing peak areas in the chromatograms with the respective peaks obtained using the malonyl-CoA standard; peak areas of serial dilutions of the standard (0, 18, 26, 72, and 144 pmol) were used to determine linear regression equations. The column was extensively washed between standards and samples to ensure no follow through of standard. The external standards were prepared with concentrations of malonyl-CoA determined by spectrophotometric absorption coefficients and then extracted as described [King and Riess (22)]. Linearity of the peak areas for external standards was obtained (r = 0.95-0.99). Identification of peaks in liver samples was based on comparing time of elution with that of malonyl-CoA standards and by verifying that the malonyl-CoA peak was eliminated after alkalinization of tissue extracts (hydrolyzing the acyl CoA ester) with consequent augmentation of CoASH peak (and serving as a negative control).

Serum triglycerides. Serum triglycerides were measured on days 21 and 120 using a commercial kit from Sigma Diagnostics (St. Louis, MO). Reagents and samples were prepared according to the manual instructions, and absorbencies were measured in a spectrophotometer at 340 nm. Reliability of test results was monitored using sample blanks as well as use of control sera of known triglyceride concentrations (Sigma Cardiolipid Control).

Statistics. All data presented are expressed as means ± SE. For animal weights, hepatic malonyl-CoA levels, and serum triglycerides, statistical analyses were performed using ANOVA (Fisher's protected least-significance difference) and Student's unpaired t-test. For RT-PCR, statistical analyses were performed using the nonparametric Wilcoxon matched-pair test comparing the IUGR to its respective sham control group.


    RESULTS
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

Animals weights. At day 60 of life (n = 6 litters), both male and female F1 IUGR rats were significantly lighter than Con rats (Table 2). At day 120 of life (n = 6 litters), IUGR male rats continued to weigh significantly less than their age-matched Con counterparts; however, in contrast, no significant difference in weight existed between day 120 IUGR and age-matched female Con rats (Table 2). Survival at day 120 did not differ between male and female rats at day 120 in either IUGR or Con groups.

                              
View this table:
[in this window]
[in a new window]
  		Table 2.   Day 60 and day 120 male and fetal rate weights

Pups (F2 generation) of the paired matings were allowed to deliver spontaneously and were weighed on day 7 of life. There was no significant difference in parental weight within groups (e.g., IUGR males from 1 set of matings were similar in weight to that of the IUGR males from another set of matings) or litter size between pairings. Pups from matings that involved either an IUGR male or female ("heterozygous" for IUGR) weighed significantly less than progeny from Con-Con matings (Table 3). Pups from matings in which both parents were IUGR weighed significantly less than matings in which one parent was IUGR (Table 3).

                              
View this table:
[in this window]
[in a new window]
  		Table 3.   Day 7 weights of Con and IUGR matings

Hepatic mRNA levels. We quantified relative mRNA levels of CPTI, HADHA, and ACC in IUGR and Con livers at days 0, 21, and 120 of life. At day 0 of life, hepatic mRNA levels of all three enzymes were significantly decreased in IUGR animals versus Con animals (Table 4 and Fig. 2A; n = 10 both for Con and IUGR). Similarly, at day 21 of life, mRNA levels of CPTI and HADHA continued to be significantly decreased, whereas mRNA levels of ACC doubled and were significantly increased (Table 4 and Fig. 2B; n = 8 both for Con and IUGR). At this age, no difference was noted between male and female animals.

                              
View this table:
[in this window]
[in a new window]
  		Table 4.   mRNA levels of CPTI, HADHA, and ACC in Con and IUGR liver expressed as percentages of Con



View larger version (48K):
[in this window]
[in a new window]
  		Fig. 2.   Quantification and representative phosphorimages of CPTI (liver isoform), HADH [alpha -subunit (HADHA)], and ACC RT-PCR products in day 0 (A), day 21 (B), day 120 female (C), and day 120 male (D) rats. RT-PCR products were quantified by phosphorimage analysis (Molecular Analyst software, BioRad). Results are expressed as mean percentages ± SE relative to the means of the age-matched controls (Con). (*P < 0.05 vs. Con)

At day 120 of life, our data were analyzed in a sex-specific context because of the relative difference in weights between IUGR male and female rats versus Con animals (n = 6 for each sex in each group). No significant difference was found between hepatic mRNA levels of CPTI, HADHA, and ACC in day 120 IUGR female livers versus age-matched Con female livers (Table 4) (Fig. 2C). However, hepatic mRNA levels of all three enzymes were significantly different between IUGR and Con males. Hepatic gene expression of CPT and HADH were significantly decreased, and hepatic gene expression of ACC was significantly increased in IUGR male rats (Table 4 and Fig. 2D).

mRNA levels of Con male and female rats at day 120 were also compared. For CPTI and HADHA mRNA, no significant difference existed between Con male and female adult rats. However, for ACC, male adult rats expressed 63 ± 9% (P < 0.05) of the mRNA levels that female adults rats expressed.

mRNA of ICD and MMD were also quantified for comparative reasons. No significance differences in mRNA levels of these enzymes were found between Con and IUGR or male and female rats at day 120 of life, respectively (Fig. 3).


View larger version (31K):
[in this window]
[in a new window]
  		Fig. 3.   Quantification and representative phosphorimages of isocitrate dehydrogenase (ICD) and mitochondrial malate dehydrogenase (MMD) in day 120 female (A) and day 120 (B) male rats. RT-PCR products were quantified by phosphorimage analysis (Molecular Analyst software, BioRad). Results are expressed as mean percentages ± SE relative to the means of the age-matched Con.

Hepatic malonyl-CoA levels. We quantified hepatic malonyl-CoA levels in day 120 IUGR female and male rats. No differences were noted in hepatic malonyl-CoA levels between day 120 female IUGR and Con rats (Con female, 0.65 ± 05 nmol/g protein; IUGR female, 0.63 ± 07 nmol/g protein; n = 6 both for Con and IUGR). In contrast, hepatic malonyl-CoA levels were significantly elevated in day 120 IUGR male rats [Con male, 0.42 ± 0.07 nmol/g protein; IUGR male, 0.72 ± 0.08 nmol/g protein (P < 0.05); n = 6 both for Con and IUGR].

Serum triglyceride levels. We quantified fasting serum triglyceride levels in days 21 and 120 Con and IUGR rats. In day 21 rats, serum triglycerides were not significantly different between the sexes or the IUGR and Con rats (IUGR, 125 ± 24 mg/dl; Con, 90 ± 10 mg/dl; n = 8 both for Con and IUGR); hence, the results in males and females were pooled.

In day 120 female rats, serum triglycerides were not significantly different between IUGR and Con animals (IUGR, 73 ± 13 mg/dl; Con, 64 ± 14 mg/dl; n = 6 both for Con and IUGR). However, serum triglycerides were increased approximately twofold in day 120 IUGR male rats versus Con [IUGR, 173 ± 30 mg/dl (P < 0.05); Con, 89 ± 11 mg/dl].


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

This present study finds changes in hepatic gene expression of key fatty acid-metabolizing enzymes CPTI, ACC, and HADHA mRNA in newborn, juvenile, and adult IUGR rats. The changes in adult male IUGR rats occur in association with increased hepatic malonyl-CoA levels and increased serum triglycerides, important markers of altered hepatic fatty acid metabolism. These novel observations are significant findings because they demonstrate a potential mechanism that links the altered in utero environment of uteroplacental insufficiency and subsequent adult dyslipidemia.

Like the human, the IUGR rat fetus is characterized by hypoxia, acidosis, altered IGF availability, hypoglycemia, and hypoinsulinemia, all of which normalize in the perinatal period (12, 39, 40, 59). Although little is reported about the effects of uteroplacental insufficiency on gene expression of hepatic fatty acid-metabolizing enzymes, our findings at day 0 of life of decreased hepatic mRNA levels of ACC, CPTI, and HADHA in the IUGR rat fetus correlate with identified mechanisms affecting their mRNA levels. For ACC, glucose and insulin levels directly regulate mRNA levels and enzyme activity so the hypoglycemia and hypoinsulinemia of the IUGR intrauterine milieu should lead to decreased hepatic ACC gene expression (16, 47). For CPTI and HADHA, coordinate mRNA levels of these genes are expected secondary to mutual dependence on Sp1 promoter binding for transcription as well as the altered redox state and oxidative stress experienced by the IUGR hepatocyte (43, 55). Oxidation of the transcription factor Sp1 decreases its DNA-binding efficiency and subsequently should decrease CPTI and HADHA transcription (1). As the hepatocyte redox state normalizes in the perinatal period, this effect should subside. The decreased expression of CPTI and HADHA, two enzymes involved in mitochondrial beta -oxidation, is also consistent with the observation in the hypertriglyceridemia of the human IUGR neonate as a result of decreased peripheral fatty acid utilization (11, 50, 58). We speculate that decreased expression of CPTI and HADHA may provide an explanation for the relative hypertriglyceridemia often observed in IUGR newborns.

By adolescence, the lipid status of IUGR human individuals normalize (2). Similarly, perturbations induced by bilateral uterine artery ligation in the rat resolve and the IUGR rat undergoes a period of overt normalcy due to an apparent masking of metabolic changes. For example, prefasting and 24-h fasting levels of insulin, glucose, and glucagon levels are not significantly different between day 21 IUGR and Con animals (41). Similarly, we also found no significant difference in fasting serum triglycerides at day 21 of life, though gene expression of ACC, CPTI, and HADHA was still altered. The lack of correlation between a pattern of gene expression that suggests net hepatic fatty acid-triglyceride synthesis (increased ACC and decreased CPTI and HADHA) and serum triglycerides may be due to an altered pattern in hepatic fatty acid-metabolism regulation found specifically in the suckling-weaning transition when malonyl-CoA does not tightly regulate mitochondrial beta -oxidation (10).

Malonyl-CoA does play a significant role in the regulation of hepatic mitochondrial fatty acid metabolism in hepatocytes from mature animals, and our findings of increased ACC and decreased CPTI and HADHA gene expression in the adult IUGR male rat parallels the increased hepatic malonyl-CoA levels and serum triglycerides, suggesting net hepatic fatty acid synthesis.

One other study has observed differences in adult fat metabolism between male and female rodents in response to in utero malnutrition. Lind et al. (29) found that induction of IUGR by maternal malnutrition caused hypercholesterolemia in the adult male guinea pig but not the female. Sexual dimorphism has also been noted in adult rat metabolism in response to an altered diet: male rats develop sucrose-induced plasma and hepatic hypertriglyceridemia, and female rats do not (19). Neither of these studies noted the effect of their intervention on hepatic gene expression.

It is also clear that human males and females process fat differently. The adult syndrome X quartet of hyperinsulinism, insulin resistance, hypertriglyceridemia, and hypertension is linked to low birth weight both in men and women; however, hepatic steatosis is more common in males than in females, and the positive relationship between insulin resistance and plasma triglycerides is weaker in women than in men (7, 32, 60). African-American men are more likely to demonstrate resistance to insulin-mediated suppression of adipocyte fatty acid release (56). These fatty acids are then available to the liver for synthesis into triglyceride-containing lipoproteins.

In contrast, adipocyte release of leptin correlates with total energy and resting energy expenditure in African-American women but not in men. The possibility that leptin may play a role in the gender differences associated with dyslipdemia and low birth weight is intriguing. The lowest levels of serum leptin concentrations are found in IUGR boys (6), and estrogen deficiency may trigger syndrome X in women (7, 8, 51, 53). We speculate estrogen deficiency would unmask differences in hepatic fatty acid gene expression and function in older sexually senescent IUGR female rats versus age-matched controls.

Our finding that progeny (F2 generation) of IUGR rats are also growth retarded regardless of which parental rat is IUGR supports the speculation that both male and female rats are affected, and moreover, suggests that the metabolic changes initiated by uteroplacental insufficiency alter gene expression by inheritable epigenetic phenomena, such as DNA methylation. Though promoter methylation patterns of the genes studied in this paper are unknown, it is likely that the epigenetic effects of uteroplacental insufficiency occur upstream in the cascade of events that regulate expression of ACC, CPTI, and HADH and allow for efficient fine tuning of multiple metabolic pathways. Our finding that low birth weight is inheritable through either parent mimics the human experience and demonstrates that nuclear genes are involved, although effects on the mitochondrial genome cannot be excluded (23, 24, 31). An epigenetic phenomena also potentially explains the observation in humans that less mortality occurs in growth-retarded infants whose mother was IUGR versus growth-retarded infants whose mother was not IUGR. The former group of infants may be growth retarded secondary to factors intrinsic to the fetus, whereas the latter group of infants is growth retarded secondary to an imposed pathological environment (49). The mechanisms by which the intrauterine milieu initiates epigenetic changes in fetal IUGR DNA should be the focus of future studies.

The association between fetal undernourishment and adult morbidities such as dyslipidemia is an important example of Barker's "Fetal Origins of Adult Disease Hypothesis" (4). This hypothesis proposes that fetal adaptation to a deprived intrauterine milieu leads to permanent changes in cellular biology and whole body physiology. These adaptations ensure the survival of the immature animal under adverse conditions but may be detrimental to the adult. Altered hepatic fatty acid metabolism may be a result of either a primary metabolic imprint or a general metabolic imprint causing a secondary effect. Either way, this study makes a novel observation of an association between in utero malnutrition and adult hepatic gene expression and function of fatty acid-metabolizing enzymes.

Caution is necessary when attempting to apply data from a rat model to human pathophysiology. The timing and impact of uteroplacental insufficiency experienced by humans range across a continuum, and the human life experience is confounded by both genetic and environmental variables. In contrast, the laboratory rat in this study is inbred and experiences a homogeneous diet and environment. The insult imposed on the fetal rat in this model of uteroplacental insufficiency is severe, occurs relatively late in gestation, and results in asymmetrical growth retardation (brain growth is spared relative to carcass growth) (54). Similarly, most human IUGR infants are also categorized as asymmetrical. Characteristics of the asymmetric IUGR infant include a low ponderal index, and common etiologies include third trimester uteroplacental dysfunction or nutritional deficiency (14).

In summary, we found that uteroplacental insufficiency and subsequent low birth weight causes alterations in hepatic gene expression of ACC, CPTI, and HADHA in fetal, juvenile, and adult male rats. The changes in the adult male rat are associated with parallel changes in hepatic malonyl-CoA levels and serum triglycerides. We speculate that these changes may contribute to the adult dyslipidemia that is associated with low birth weight.

Perspectives

Our study focuses on the fetal origins of adult disease. We induce changes in fetal hepatic gene expression through uteroplacental insufficiency, a common human condition. The progression of the altered gene expression varies depending on the time of life and the sex of the animal, yet both sexes are affected based on the phenotype of the F2 progeny in our study. Future research will focus on which phenomena are primary effects of an altered intrauterine milieu and which are secondary effects. We speculate that the primary effect in this study is a "metabolic imprint" on the fetal DNA that initiates or selects a lifelong metabolic program that endows the IUGR individual with a potential evolutionary advantage. A teleological explanation of our findings credits the fetus with interpreting the deprived intrauterine milieu as foreshadowing an adverse ex utero environment. If the IUGR fetus actively adapts to this prospective environment by programming the liver toward increased fatty acid synthesis or decreased fatty acid oxidation, then an increased supply of hepatic triglycerides may decrease skeletal muscle insulin sensitivity and spare glucose for the relatively large brain of the IUGR individual. Furthermore, transgenerational inheritance of growth retardation provides a selective group advantage by potentially allowing more bodies to fit into a limited environment. Recent advances in human life span and diet expose the morbidities associated with these and similar adaptations, particularly in western society, and thereby lead to a fetal origin of adult disease.


    ACKNOWLEDGEMENTS

We thank Nicole MacLennan for help in the preparation of this manuscript.


    FOOTNOTES

This research was supported by National Institute of Child Health and Human Development Grants P30HD-28836-05 (R. H. Lane), 1KO8BD01225-01 (R. H. Lane), P30HD-04612 (R. H. Lane), HD-33997 (S. U. Devaskar), and HD-25024 (S. U. Devaskar) and the Magee Womens Hospital "25" club.

Address for reprint requests and other correspondence: R. H. Lane, Mattel Children's Hospital @ UCLA, B2-375 MDCC, 10833 Le Conte Ave., Los Angeles, CA 90095 (E-mail: rlane{at}mednet.ucla.edu).

The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Received 6 June 2000; accepted in final form 5 September 2000.


    REFERENCES
TOP
ABSTRACT
INTRODUCTION
METHODS
RESULTS
DISCUSSION
REFERENCES

1.   Ammendola, R, Mesurac M, Russo T, and Cimino F. The DNA-binding efficiency of Sp1 is affected by redox changes. Eur J Biochem 225: 483-489, 1994[ISI][Medline].

2.   Antal, M, Agfalvi R, Nagy K, Szepvolgi J, Banto E, Regoly-Merei A, Biro L, and Biro G. Lipid status in adolescents born with low brith weight. Eur J Nutr 37S1: 131-133, 1998.

3.   Barker, DJ. Intrauterine programming of coronary heart disease and stroke. Acta Paediatr Suppl 423: 178-182, 1997[Medline].

4.   Barker, DJP Fetal origins of cardiovascular disease. Ann Med Suppl 1: 3-6, 1999.

5.   Barker, DJP, Hales CN, Fall CHD, Osmond C, Phipps K, and Clark PMS Type 2 (non-insulin dependent) diabetes mellitus, hypertension, and hyperlipidaemia (syndrome X): relation to reduced fetal growth. Diabetologia 36: 62-67, 1993[ISI][Medline].

6.   Boguszewski, M, Dahlgren J, Bjarnsason R, Rosberg S, Carlsson LMS, Carlsson B, and Albertsson-Wikland K. Serum leptin in short children born small for gestation age: relationship with the growth response to growth hormone. Eur J Endocrinol 137: 387-395, 1997[Abstract].

7.   Brann, DW, De Sevilla L, Zamorano PL, and Mahesh VB. Regulation of leptin gene expression and secretion by steroid hormones. Steroids 64: 659-663, 1999[ISI][Medline].

8.   Cella, F, Giordano G, and Cordera R. Serum leptin concentrations during menstrual cycle in normal weight women: effects of an oral triphasic estrogen-progestin medication. Eur J Endocrinol 142: 174-178, 2000[Abstract].

9.   Chomczynski, P, and Sacchi N. Single step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987[ISI][Medline].

10.   Decaux, JF, Ferre P, Robin D, Robin P, and Girard J. Decreased hepatic fatty acid oxidation at weaning in the rat is not linked to a variation of malonyl-CoA concentration. J Biol Chem 263: 3284-3289, 1988[Abstract/Free Full Text].

11.   Economides, DL, Crook D, and Nicolaides KH. Investigation of hypertriglyceridemia in small for gestational age fetuses. Fetal Ther 3: 165-172, 1988[Medline].

12.   Economides, DL, Nicolaides KH, and Campbell S. Metabolic and endocrine findings in appropriate and small for gestation age fetuses. J Perinat Med 19: 97-105, 1991[ISI][Medline].

13.   Esser, V, Britton CH, Weis BC, Foster DW, and McGarry JD. Cloning, sequencing, and expression of cDNA encoding rat liver carnitine palmitoyltransferase I. J Biol Chem 268: 5817-5822, 1993[Abstract/Free Full Text].

14.   Fanaroff, AA, and Martin RJ. Neonatal-Perinatal Medicine: Diseases of the Fetus and Infant. St. Louis, MO: Mosby, 1997, p. 222-224.

15.   Fukuda, H, Katsurada A, and Iritani N. Nutritional and hormonal regulation of mRNA levels of lipogenic enzymes in primary cultures of rat hepatocytes. J Biochem 111: 25-32, 1992[Abstract/Free Full Text].

16.   Fukuda, H, and Nobuko I. Effects of aging on gene expression of acetyl-CoA carboxylase and fatty acid synthase in rat liver. J Biochem 112: 277-280, 1992[Abstract/Free Full Text].

17.   Grant, PM, Tellam J, May VL, and Strauss AW. Isolation and nucleotide sequence of a cDNA clone encoding rat mitochondrial malate dehydrogenase. Nucleic Acid Res 14: 6053-6066, 1986[Abstract/Free Full Text].

18.   Holliday, R. The inheritance of epigenetic defects. Science 238: 163-170, 1987[Abstract/Free Full Text].

19.   Horton, TJ, Gayles EC, Prach PA, Koppenhafer TA, and Pagliassotti MJ. Female rats do not develop sucrose-induced insulin resistance. Am J Physiol Regulatory Integrative Comp Physiol 272: R1571-R1576, 1997[Abstract/Free Full Text].

20.   Kamijo, T, Aoyama T, Komiyama T, and Hashimoto T. Structural analysis of cDNAs for subunits of human mitochondrial fatty acid beta -oxidation trifunctional protein. Biochem Biophys Res Commun 199: 818-825, 1994[ISI][Medline].

21.   Kamijo, T, Aoyama T, Miyazaki J, and Hashimoto T. Molecular cloning of the cDNAs for the subunits of rat mitochondrial fatty acid beta-oxidation multienzyme complex. Structural and functional relationships to other mitochondrial and peroxisomal beta-oxidation enzymes. J Biol Chem 268: 26452-26460, 1993[Abstract/Free Full Text].

22.   King, MT, and Reiss PD. Separation and measurement of short-chain coenzyme A compounds in rat liver by reversed-phase high-performance liquid chromatography. Anal Biochem 146: 173-179, 1985[ISI][Medline].

23.   Klebanoff, MA, Mednick BR, Schulsinger C, Secher NJ, and Shiono PH. Father's effect on infant birth weight. Am J Obstet Gynecol 178: 1022-1026, 1998[ISI][Medline].

24.   Klebanoff, MA, and Yip R. Influence of maternal birth weight on rate of fetal growth and duration of gestation. J Pediatr 111: 287-293, 1987[ISI][Medline].

25.   Lane, RH, Chandorkar AK, Flozak AS, and Simmons RA. Intrauterine growth retardation alters mitochondrial gene expression and function in fetal and juvenile rat skeletal muscle. Pediatr Res 43: 563-570, 1998[ISI][Medline].

26.   Lane, RH, Crawford SE, Flozak AS, and Simmons RA. Localization and quantification of glucose transporters in liver of growth retarded fetal and neonatal rats. Am J Physiol Endocrinol Metab 276: E135-E142, 1999[Abstract/Free Full Text].

27.   Lane, RH, Flozak AS, Ogata ES, Bell GI, and Simmons RA. Altered hepatic gene expression of enzymes involved in energy metabolism in the growth retarded fetal rat. Pediatr Res 39: 390-394, 1996[ISI][Medline].

28.   Lane, RH, Flozak AS, and Simmons RA. Measurement of GLUT mRNA in liver of fetal and neonatal rats using a novel method of quantitative polymerase chain reaction. Biochem Mol Med 59: 92-199, 1996.

29.   Lind, KL, Clifton PM, Katsman AI, Tsiounis M, Robinson JS, and Owens JA. Restricted fetal growth and response to dietary cholesterol in the guinea pig. Am J Physiol Regulatory Integrative Comp Physiol 277: R1675-R1692, 1999[Abstract/Free Full Text].

30.   Lopez-Casillas, F, Bai DH, Luo XC, Kong IS, Hermodson MA, and Kim KH. Structure of the coding sequence and primary amino acid sequence of acetyl-coenzyme A carboxylase. Proc Natl Acad Sci USA 85: 5784-5788, 1988[Abstract/Free Full Text].

31.   Magnus, P, Bakketeig LS, and Hoffman H. Birth weight of relatives by maternal tendency to repeat small-for-gestational-age (SGA) births in successive pregnancies. Acta Obstet Scand Suppl 165: 34-38, 1997.

32.   Marceau, P, Biron S, Hould FS, Marceau S, Simard S, Thung SN, and Kral JG. Liver pathology and the metabolic syndrome X in severe obesity. J Clin Endocrinol Metab 84: 1513-1517, 1999[Abstract/Free Full Text].

33.   McGarry, JD, and Brown NF. The mitochondrial carnitine palmitoyltransferase system; from concept to molecular analysis. Eur J Biochem 244: 1-14, 1997[ISI][Medline].

34.   McGarry, JD, Takabayashi Y, and Foster DW. The role of malonyl-CoA in the coordination of fatty acid synthesis and oxidation in isolated rat hepatocytes. J Biol Chem 253: 8294-8300, 1978[Abstract/Free Full Text].

35.   Middleton, B. The mitochondrial long-chain trifunctional enzyme: 2-enoyl-CoA hydratase, 3-hydroxyacyl-CoA dehydrogenase, and 3-oxoacyl-CoA thiolase. Biochem Soc Trans 22: 427-431, 1994[ISI][Medline].

36.   Morgan, HD, Sutherland HG, Martin DI, and Whitelaw E. Epigenetic inheritance at the agouti locus in the mouse. Nat Genet 23: 314-318, 1999[ISI][Medline].

37.   Munday, MR, and Hemingway CJ. The regulation of acetyl-CoA carboxylase-a potential target for the action of hypolipidemic agents. Adv Enzyme Regul 39: 205-234, 1999[ISI][Medline].

38.   Nichols, BJ, Hall L, Perry AC, and Denton RM. Molecular cloning and deduced amino acid sequences of the gamma-subunits of rat and monkey NAD(+)-isocitrate dehydrogenase. Biochem J 295: 347-350, 1993.

39.   Nicolaides, KH, Economides DL, and Soothill PW. Blood gases, pH, and lactate in appropriate and small for gestation age fetuses. Am J Obstet Gynecol 161: 996-1001, 1989[ISI][Medline].

40.   Ogata, ES, Bussey ME, and Finley S. Altered gas exchange, limited glucose and branched chain amino acids and hypoinsulinemism retard fetal growth in the rat. Metabolism 35: 970-977, 1985.

41.   Ogata, ES, Bussey ME, LaBarbera A, and Finley S. Altered growth, hypoglycemia, hypoalaninemia, and ketonemia in the young rat: postnatal consequences of intrauterine growth retardation. Pediatr Res 19: 32-37, 1985[ISI][Medline].

42.   Ogata, ES, Swanson SL, Collins JW, and Finley SL. Intrauterine growth retardation: altered hepatic energy and redox states in the fetal rat. Pediatr Res 27: 56-63, 1990[ISI][Medline].

43.   Orii, KE, Orii KO, Souri M, Orii T, Kondo N, Hashimoto T, and Aoyama T. Genes for the human mitochondrial trifunctional protein alpha and beta-subunits are divergently transcribed from a common promoter region. J Biol Chem 274: 8077-8084, 1999[Abstract/Free Full Text].

44.   Orii, KE, Toshifumi A, Souri M, Jiang LL, Orii KO, Hayashi S, Yamaguchi S, Kondo N, Orii T, and Hashimoto T. Formation of the enzyme complex in mitochondria is required for function of trifunctional beta -oxidation protein. Biochem Biophys Res Commun 219: 773-777, 1996[ISI][Medline].

45.   Pape, ME, Lopez-Casillas F, and Kim K. Physiological regulation of acetyl-CoA carboxylase gene expression: effects of diet, diabetes, and lactation on acetyl-CoA carboxylase mRNA. Arch Biochem Biophys 257: 63-68, 1988.

46.   Park, EA, Mynatt RL, Cook GA, and Kashfi K. Insulin regulates enzyme activity, malonyl-CoA sensitivity and mRNA abundance of hepatic carnitine palmitoyltransferase-I. Biochem J 310: 853-858, 1995.

47.   Porter, JW, and Swenson TL. Induction of fatty acid synthetase and acetyl-CoA carboxylase by isolated rat liver cells. Mol Cell Biochem 43: 307-325, 1983.

48.   Rasmussen, BB, and Wolfe RR. Regulation of fatty acid oxidation in skeletal muscle. Annu Rev Nutr 19: 463-484, 1999[ISI][Medline].

49.   Read, AW, and Stanley FJ. A comparision of recurrent and isolated small-for-gestational-age term births. Paediatr Perinat Epidemiol 5: 138-156, 1991[Medline].

50.   Roberts, A, Nava S, Bocconi L, Salmona S, and Nicolini U. Liver function tests and glucose and lipid metabolism in growth restricted fetuses. Obstet Gynecol 94: 290-294, 1999[Abstract/Free Full Text].

51.   Rosano, GM, Collins P, Kaski JC, Lindsay DC, Sarrel PM, and Poole-Wilson PA. Syndrome X in women is associated with oestrogen deficiency. Eur Heart J 16: 610-614, 1995[Abstract/Free Full Text].

52.   Salway, JG. Metabolism at a Glance. Oxford: Blackwell Scientific, 1994, p. 28-31.

53.   Schenck-Gustafsson, K. Risk factors for cardiovascular disease in women: assessment and management. Eur Heart J 17, Suppl D: 2-8, 1996.

54.   Simmons, RA, Gounis AS, Bangalore SA, and Ogata ES. Intrauterine growth retardation: fetal glucose transport is diminished in lung but spared in brain. Pediatr Res 31: 59-63, 1992[ISI][Medline].

55.   Steffen, ML, Harrison WR, Elder FF, Cook GA, and Park EA. Expression of the rat liver carnitine palmitoyltransferase I (CPT-Ialpha) gene is regulated by Sp1 and nuclear factor Y: chromosomal localization and promoter characterization. Biochem J 340: 425-432, 1999.

56.   Sumner, AE, Kushner H, Tulenko TN, Falkner B, and Marsh JB. The relationship in African-Americans of sex differences in insulin mediated supression of nonesterified fatty acids to sex differences in fasting triglyceride levels. Metabolism 46: 400-405, 1997[ISI][Medline].

57.   Takeyama, N, Takagi D, Adachi K, and Tanaka T. Measurement of free and esterified carnitine in tissue extracts by high-performance liquid chromatography. Anal Biochem 158: 346-354, 1986[ISI][Medline].

58.   Toce, SS, and Keenan WJ. Lipid intolerance in newborns is associated with hepatic dysfunction but not infection. Arch Pediatr Adolesc Med 149: 1249-1253, 1995[Abstract].

59.   Unterman, TG, Simmons RA, Glick RP, and Ogata ES. Circulating levels of insulin, insulin-like growth factor-I (IGF-I), IGF-II, and IGF-binding proteins in the small for gestational age fetal rat. Endocrinology 132: 327-336, 1993[Abstract].

60.   Yarbrough, DE, Barrett-Conner E, Kritz-Silverstein D, and Wingard DL. Birth weight, adult weight, and girth as predictors of the metabolic syndrome in postmenopausal women: the Rancho Bernardo study. Diabetes Care 21: 1652-1658, 1998[Abstract].

61.   Yokata, S, and Hasimoto T. Inner membrane association of three mitochondrial beta -oxidation enzymes revealed by immunoelectron microscopic technique. Histochemistry 80: 547-552, 1984[ISI][Medline].

Am J Physiol Regul Integr Comp Physiol 280(1):R183-R190
0363-6119/01 $5.00 Copyright © 2001 the American Physiological Society


This article has been cited by other articles:


Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
E. A. O'Brien, V. Barnes, L. Zhao, R. A. McKnight, X. Yu, C. W. Callaway, L. Wang, J. C. Sun, M. J. Dahl, A. Wint, et al.
Uteroplacental insufficiency decreases p53 serine-15 phosphorylation in term IUGR rat lungs
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2007; 293(1): R314 - R322.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. GenomicsHome page
X. Ke, Q. Lei, S. J. James, S. L. Kelleher, S. Melnyk, S. Jernigan, X. Yu, L. Wang, C. W. Callaway, G. Gill, et al.
Uteroplacental insufficiency affects epigenetic determinants of chromatin structure in brains of neonatal and juvenile IUGR rats
Physiol Genomics, March 13, 2006; 25(1): 16 - 28.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. Baserga, M. A. Hale, R. A. McKnight, X. Yu, C. W. Callaway, and R. H. Lane
Uteroplacental insufficiency alters hepatic expression, phosphorylation, and activity of the glucocorticoid receptor in fetal IUGR rats
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2005; 289(5): R1348 - R1353.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Endocrinol. Metab.Home page
W. Shen, P. Wisniowski, S. C. Denne, D. W. Boyle, and E. A. Liechty
Anabolic effects of insulin and IGF-I in the ovine fetus are reduced by prolonged maternal fasting
Am J Physiol Endocrinol Metab, May 1, 2005; 288(5): E907 - E913.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. Rev.Home page
I. C. Mcmillen and J. S. Robinson
Developmental Origins of the Metabolic Syndrome: Prediction, Plasticity, and Programming
Physiol Rev, April 1, 2005; 85(2): 571 - 633.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
X. Ke, R. A. McKnight, Z.-m. Wang, X. Yu, L. Wang, C. W. Callaway, K. H. Albertine, and R. H. Lane
Nonresponsiveness of cerebral p53-MDM2 functional circuit in newborn rat pups rendered IUGR via uteroplacental insufficiency
Am J Physiol Regulatory Integrative Comp Physiol, April 1, 2005; 288(4): R1038 - R1045.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. GenomicsHome page
Q. Fu, R. A. McKnight, X. Yu, L. Wang, C. W. Callaway, and R. H. Lane
Uteroplacental insufficiency induces site-specific changes in histone H3 covalent modifications and affects DNA-histone H3 positioning in day 0 IUGR rat liver
Physiol Genomics, December 15, 2004; 20(1): 108 - 116.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. He, A. Varma, L. A. Weissfeld, and S. U. Devaskar
Postnatal glucocorticoid exposure alters the adult phenotype
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2004; 287(1): R198 - R208.
[Abstract] [Full Text] [PDF]

Home page
 Physiol. GenomicsHome page
N. K. MacLennan, S. J. James, S. Melnyk, A. Piroozi, S. Jernigan, J. L. Hsu, S. M. Janke, T. D. Pham, and R. H. Lane
Uteroplacental insufficiency alters DNA methylation, one-carbon metabolism, and histone acetylation in IUGR rats
Physiol Genomics, June 17, 2004; 18(1): 43 - 50.
[Abstract] [Full Text] [PDF]

Home page
 J. Nutr.Home page
C. W. Kuzawa
Modeling Fetal Adaptation to Nutrient Restriction: Testing the Fetal Origins Hypothesis with a Supply-Demand Model
J. Nutr., January 1, 2004; 134(1): 194 - 200.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
T. D. Pham, N. K. MacLennan, C. T. Chiu, G. S. Laksana, J. L. Hsu, and R. H. Lane
Uteroplacental insufficiency increases apoptosis and alters p53 gene methylation in the full-term IUGR rat kidney
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2003; 285(5): R962 - R970.
[Abstract] [Full Text] [PDF]

Home page
 Int J EpidemiolHome page
L. Lauren, M.-R. Jarvelin, P. Elliott, U. Sovio, A. Spellman, M. McCarthy, P. Emmett, I. Rogers, A.-L. Hartikainen, A. Pouta, et al.
Relationship between birthweight and blood lipid concentrations in later life: evidence from the existing literature
Int. J. Epidemiol., October 1, 2003; 32(5): 862 - 876.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
K. L. Kind, P. M. Clifton, P. A. Grant, P. C. Owens, A. Sohlstrom, C. T. Roberts, J. S. Robinson, and J. A. Owens
Effect of maternal feed restriction during pregnancy on glucose tolerance in the adult guinea pig
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2003; 284(1): R140 - R152.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
J. P. Granger
Maternal and fetal adaptations during pregnancy: lessons in regulatory and integrative physiology
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2002; 283(6): R1289 - R1292.
[Full Text] [PDF]

Home page
 Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
R. H. Lane, B. Dvorak, N. K. MacLennan, K. Dvorakova, M. D. Halpern, T. D. Pham, and A. F. Philipps
IGF alters jejunal glucose transporter expression and serum glucose levels in immature rats
Am J Physiol Regulatory Integrative Comp Physiol, December 1, 2002; 283(6): R1450 - R1460.
[Abstract] [Full Text] [PDF]

This Article